» Articles » PMID: 15154744

Virtual Screening Using Protein-ligand Docking: Avoiding Artificial Enrichment

Overview
Date 2004 May 25
PMID 15154744
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

This study addresses a number of topical issues around the use of protein-ligand docking in virtual screening. We show that, for the validation of such methods, it is key to use focused libraries (containing compounds with one-dimensional properties, similar to the actives), rather than "random" or "drug-like" libraries to test the actives against. We also show that, to obtain good enrichments, the docking program needs to produce reliable binding modes. We demonstrate how pharmacophores can be used to guide the dockings and improve enrichments, and we compare the performance of three consensus-ranking protocols against ranking based on individual scoring functions. Finally, we show that protein-ligand docking can be an effective aid in the screening for weak, fragment-like binders, which has rapidly become a popular strategy for hit identification. All results presented are based on carefully constructed virtual screening experiments against four targets, using the protein-ligand docking program GOLD.

Citing Articles

Virtual screening: hope, hype, and the fine line in between.

Nada H, Meanwell N, Gabr M Expert Opin Drug Discov. 2025; 20(2):145-162.

PMID: 39862145 PMC: 11844436. DOI: 10.1080/17460441.2025.2458666.


Do Molecular Fingerprints Identify Diverse Active Drugs in Large-Scale Virtual Screening? (No).

Venkatraman V, Gaiser J, Demekas D, Roy A, Xiong R, Wheeler T Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204097 PMC: 11356940. DOI: 10.3390/ph17080992.


Fluorinated Diaryl Sulfonamides: Molecular Modeling, Synthesis, and Validation as New CETP Inhibitors.

Abu Khalaf R, Shalluf A, Habash M Curr Comput Aided Drug Des. 2023; 20(6):987-997.

PMID: 37855352 DOI: 10.2174/0115734099268407230927113905.


Design of Tetra-Peptide Ligands of Antibody Fc Regions Using In Silico Combinatorial Library Screening.

Jukic M, Kralj S, Kolaric A, Bren U Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37631085 PMC: 10459493. DOI: 10.3390/ph16081170.


Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors.

Batista V, Goncalves A, Nascimento-Junior N Molecules. 2022; 27(23).

PMID: 36500328 PMC: 9735964. DOI: 10.3390/molecules27238236.